Pfizer Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Apr 2022 | $101.16B | $183.84B | $2.47B |
| Jul 2022 | $107.82B | $195.29B | $1.78B |
| Oct 2022 | $102.46B | $195.35B | $1.30B |
| Dec 2022 | $101.29B | $197.21B | $416.0M |
| Apr 2023 | $94.38B | $195.62B | $2.17B |
| Jul 2023 | $120.88B | $220.17B | $2.63B |
| Oct 2023 | $117.82B | $215.02B | $3.15B |
| Dec 2023 | $137.21B | $226.50B | $2.85B |
| Mar 2024 | $128.54B | $221.10B | $719.0M |
| Jun 2024 | $128.22B | $216.19B | $1.05B |
| Sep 2024 | $126.92B | $219.48B | $1.09B |
| Dec 2024 | $124.90B | $213.40B | $1.04B |
| Mar 2025 | $117.39B | $208.03B | $1.43B |
| Jun 2025 | $117.08B | $206.10B | $1.64B |
| Sep 2025 | $115.64B | $208.73B | $1.34B |
| Dec 2025 | $121.39B | $208.16B | $1.14B |
| Mar 2026 | $117.21B | $207.62B | $1.70B |
| Jun 2026 | $115.64B | $201.13B | $976.0M |